Premium
The impact of antineutrophil cytoplasmic antibody‐associated vasculitis on employment and work disability in an Australian population
Author(s) -
Heron Vanessa,
Gingold Michael,
Kitching Arthur R.,
Polkinghorne Kevan R.,
Ryan Jessica
Publication year - 2021
Publication title -
international journal of rheumatic diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.795
H-Index - 41
eISSN - 1756-185X
pISSN - 1756-1841
DOI - 10.1111/1756-185x.14131
Subject(s) - medicine , vasculitis , anti neutrophil cytoplasmic antibody , disability pension , population , cohort , disease , physical therapy , environmental health
Aim Although antineutrophil cytoplasmic antibody‐associated vasculitis (AAV) most commonly affects older individuals, many patients develop the disease during their most productive working years. The aim of this study was to examine the effects of AAV on employment and work disability in a cohort of Australian patients of working age. Methods Patients attending a vasculitis clinic located in Melbourne, Australia, completed an employment questionnaire in addition to the Work Productivity and Activity Impairment Questionnaire: Specific Health Problem. Results The average age of the 47 respondents was 47.8 ± 11.9 years (range 22‐63 years), with a median disease duration of 60 months (range 10.2‐318.5 months). There were 68.1% who were currently employed, but 20.6% of respondents employed at the time of diagnosis were no longer working and 10.6% had experienced a significant reduction in work hours since their diagnosis. There were 12.7% who were dependent on the disability support pension. The rate of work disability was 23.4%. Many participants considered themselves work impaired (41.9%), with 10.1% having missed work in the previous week. Furthermore, 44.7% of respondents reported that their financial stability had been negatively impacted by their vasculitis diagnosis. Fatigue was commonly reported. Work disabled patients were significantly more likely to be obese and less likely to have completed a tertiary education. Work disabled patients tended to be older, myeloperoxidase‐antineutrophil cytoplasmic antibody positive, and have renal involvement and lung involvement. Conclusion A proportion of people living with AAV in Australia experience a decline in employment and an increase in work disability when living with this condition.